Bokde AL

References (3)

Title : Effects of rivastigmine on visual attention in subjects with amnestic mild cognitive impairment: A serial functional MRI activation pilot-study - Bokde_2016_Psychiatry.Res_249_84
Author(s) : Bokde AL , Cavedo E , Lopez-Bayo P , Lista S , Meindl T , Born C , Galluzzi S , Faltraco F , Dubois B , Teipel SJ , Reiser M , Moller HJ , Hampel H
Ref : Psychiatry Res , 249 :84 , 2016
Abstract : A pilot study to investigate the effects of rivastigmine on the brain activation pattern due to visual attention tasks in a group of amnestic Mild Cognitive Impaired patients (aMCI). The design was an initial three-month double blind period with a rivastigmine and placebo arms, followed by a nine-month open-label period. All patients underwent serial functional magnetic resonance imaging (fMRI) at baseline, and after three and six months of follow-up. Primary endpoint was the effect of rivastigmine on functional brain changes during visual attention (face and location matching) tasks. There were five in the rivastigmine arm and two in the placebo arm. The face matching task showed higher activation of visual areas after three months of treatment but no differences compared to baseline at six months. The location matching task showed a higher activation along the dorsal visual pathway at both three and six months follow ups. Treatment with rivastigmine demonstrates a significant effect on brain activation of the dorsal visual pathway during a location matching task in patients with aMCI. Our data support the potential use of task fMRI to map specific treatment effects of cholinergic drugs during prodromal stages of Alzheimer's disease (AD).
ESTHER : Bokde_2016_Psychiatry.Res_249_84
PubMedSearch : Bokde_2016_Psychiatry.Res_249_84
PubMedID: 26851974

Title : Brain networks. Correlated gene expression supports synchronous activity in brain networks - Richiardi_2015_Science_348_1241
Author(s) : Richiardi J , Altmann A , Milazzo AC , Chang C , Chakravarty MM , Banaschewski T , Barker GJ , Bokde AL , Bromberg U , Buchel C , Conrod P , Fauth-Buhler M , Flor H , Frouin V , Gallinat J , Garavan H , Gowland P , Heinz A , Lemaitre H , Mann KF , Martinot JL , Nees F , Paus T , Pausova Z , Rietschel M , Robbins TW , Smolka MN , Spanagel R , Strohle A , Schumann G , Hawrylycz M , Poline JB , Greicius MD
Ref : Science , 348 :1241 , 2015
Abstract : During rest, brain activity is synchronized between different regions widely distributed throughout the brain, forming functional networks. However, the molecular mechanisms supporting functional connectivity remain undefined. We show that functional brain networks defined with resting-state functional magnetic resonance imaging can be recapitulated by using measures of correlated gene expression in a post mortem brain tissue data set. The set of 136 genes we identify is significantly enriched for ion channels. Polymorphisms in this set of genes significantly affect resting-state functional connectivity in a large sample of healthy adolescents. Expression levels of these genes are also significantly associated with axonal connectivity in the mouse. The results provide convergent, multimodal evidence that resting-state functional networks correlate with the orchestrated activity of dozens of genes linked to ion channel activity and synaptic function.
ESTHER : Richiardi_2015_Science_348_1241
PubMedSearch : Richiardi_2015_Science_348_1241
PubMedID: 26068849

Title : Donepezil impairs memory in healthy older subjects: behavioural, EEG and simultaneous EEG\/fMRI biomarkers - Balsters_2011_PLoS.One_6_e24126
Author(s) : Balsters JH , O'Connell RG , Martin MP , Galli A , Cassidy SM , Kilcullen SM , Delmonte S , Brennan S , Meaney JF , Fagan AJ , Bokde AL , Upton N , Lai R , Laruelle M , Lawlor B , Robertson IH
Ref : PLoS ONE , 6 :e24126 , 2011
Abstract : Rising life expectancies coupled with an increasing awareness of age-related cognitive decline have led to the unwarranted use of psychopharmaceuticals, including acetylcholinesterase inhibitors (AChEIs), by significant numbers of healthy older individuals. This trend has developed despite very limited data regarding the effectiveness of such drugs on non-clinical groups and recent work indicates that AChEIs can have negative cognitive effects in healthy populations. For the first time, we use a combination of EEG and simultaneous EEG/fMRI to examine the effects of a commonly prescribed AChEI (donepezil) on cognition in healthy older participants. The short- and long-term impact of donepezil was assessed using two double-blind, placebo-controlled trials. In both cases, we utilised cognitive (paired associates learning (CPAL)) and electrophysiological measures (resting EEG power) that have demonstrated high-sensitivity to age-related cognitive decline. Experiment 1 tested the effects of 5 mg/per day dosage on cognitive and EEG markers at 6-hour, 2-week and 4-week follow-ups. In experiment 2, the same markers were further scrutinised using simultaneous EEG/fMRI after a single 5 mg dose. Experiment 1 found significant negative effects of donepezil on CPAL and resting Alpha and Beta band power. Experiment 2 replicated these results and found additional drug-related increases in the Delta band. EEG/fMRI analyses revealed that these oscillatory differences were associated with activity differences in the left hippocampus (Delta), right frontal-parietal network (Alpha), and default-mode network (Beta). We demonstrate the utility of simple cognitive and EEG measures in evaluating drug responses after acute and chronic donepezil administration. The presentation of previously established markers of age-related cognitive decline indicates that AChEIs can impair cognitive function in healthy older individuals. To our knowledge this is the first study to identify the precise neuroanatomical origins of EEG drug markers using simultaneous EEG/fMRI. The results of this study may be useful for evaluating novel drugs for cognitive enhancement.
ESTHER : Balsters_2011_PLoS.One_6_e24126
PubMedSearch : Balsters_2011_PLoS.One_6_e24126
PubMedID: 21931653